Mtaz Tablets 15mg

Product Description

Product Name: Mtaz Tablets 15mg

Product Form: Tablets

Pack Size: 20's

Manufactured By: Cell Laboratories

Used For:

1. Major Depressive Disorder (MDD):
   • Primarily used to treat depression by improving mood, sleep, and appetite.
2. Anxiety Disorders (Off-Label Use):
   • Used in generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder.
3. Insomnia (Off-Label Use):
   • Helps improve sleep due to its sedative effects.
4. Appetite Stimulation:
   • Often prescribed for patients with depression who experience significant weight loss or poor appetite.
5. Post-Traumatic Stress Disorder (PTSD) (Off-Label Use).
6. Neuropathic Pain (Off-Label Use):
   • Occasionally used to manage chronic pain conditions.

Side Effects:

• Common Side Effects:

  • Sedation or drowsiness (more pronounced at lower doses).
  • Increased appetite and weight gain.
  • Dry mouth.
  • Constipation.
  • Dizziness.

• Less Common Side Effects:

  • Restlessness or agitation.
  • Low blood pressure (orthostatic hypotension).
  • Strange dreams or vivid nightmares.
  • Swelling in extremities (edema).

• Serious Side Effects (Seek Medical Attention):

  • Suicidal Thoughts: Particularly in younger patients.
  • Low Sodium Levels (Hyponatremia): Symptoms include confusion or seizures.
  • Neutropenia/Agranulocytosis: Rarely, it can suppress white blood cell production, increasing infection risk.
  • Serotonin Syndrome: If used with other serotonergic drugs.

Precautions:

1. Medical History:

   • Inform your doctor if you have:
     • Bipolar disorder (risk of manic episodes).
     • Liver or kidney disease (may require dosage adjustments).
     • Seizures or epilepsy.
     • Glaucoma.
   • Avoid in patients with a known hypersensitivity to Mirtazapine.

2. Drug Interactions:

   • Avoid combining with MAO inhibitors (e.g., phenelzine, tranylcypromine).
   • Caution with other CNS depressants (e.g., alcohol, benzodiazepines).
   • Risk of serotonin syndrome when combined with SSRIs, SNRIs, or other serotonergic drugs.

3. Pregnancy and Breastfeeding:

   • Use only if benefits outweigh risks; safety during pregnancy is not well-established.
   • Excreted in breast milk, so caution is advised.

4. Driving and Operating Machinery:

   • May cause drowsiness or impair judgment, especially at the start of treatment.

5. Monitoring:

   • Regular follow-ups to assess response and side effects.
   • Monitor for worsening depression or suicidal ideation, particularly in the first few weeks of treatment.